Camber launches generic Thyro-Tabs
PISCATAWAY, N.J. – Camber Pharmaceuticals is pleased to announce the addition of levothyroxine sodium tablets, USP to its current portfolio. Levothyroxine sodium tablets, USP are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism, and as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated
